A subsidiary of Gilead Sciences, Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered ...

That large bird of prey soaring lazily above the motorway? In Britain, it's likely either a buzzard or a red kite. While both are increasingly common sights across UK skies, telling them apart is ...

Followed categories will be added to My News. Hulking 16-year-old Sio Kite, a 200cm tall and 140kg young star, has signed with French club Stade Rochelais, ending a week of turmoil that had the ...

Pharma companies wanted to change antibiotic use “on their own terms and not the government telling them what to do,” according to Hansen. “If they could show just a little bit of good faith ...

The “tidal power station” is neon-colored, eye-catching yellow, and swims against sea currents like a kite penetrating the air. Its onboard system turns its rudders to direct it in an 8-shape pattern ...

Opinions expressed are those of the author. 2025 is going to be a big year for AI adoption in pharma. By now, most life science companies have at least experimented with one generative AI (GenAI ...

Starboard Commercial Real Estate listed an Emeryville, California, data center for sale in a test for the market, which doesn't often see data centers change hands. Starboard is asking $6.5M ...

Lilly is set to generate 3,000 employment opportunities for skilled professionals across the four sites. Credit: JHVEPhoto/Shutterstock. Eli Lilly has announced plans to expand its domestic medicine ...

Pakistan Single Window (PSW) CEO Syed Aftab Haider has said that digitalisation of regulatory processes will simplify compliance requirement and help pharmaceutical firms to reduce the time and ...

Gland Pharma Ltd on Tuesday (February 25) announced that America's drug regulatory watchdog has completed a crucial inspection of its Andhra Pradesh facility. In a regulatory filing, Gland Pharma said ...

Sutter Health purchased a 12-acre life sciences campus in Emeryville for $450 million. The health care firm plans to redevelop the site into a 1.3-million-square-foot hospital and medical center ...

Its time for Indian pharma companies to look beyond the U.S. market as the Trump administration has threatened to impose 25% tariff on pharmaceutical imports. This move would disrupt India’s ...